Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
11,764,939
-
Total 13F shares
-
267,804
-
Share change
-
+126,847
-
Total reported value
-
$832,000
-
Price per share
-
$3.10
-
Number of holders
-
13
-
Value change
-
+$409,973
-
Number of buys
-
11
-
Number of sells
-
2
Institutional Holders of Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) as of Q3 2020
As of 30 Sep 2020,
Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
267,804 shares.
The largest 10 holders included
BlackRock Inc., SABBY MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, Squarepoint Ops LLC, ExodusPoint Capital Management, LP, and Tower Research Capital LLC (TRC).
This page lists
12
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.